High-Content, High-Throughput Analysis of Cell Cycle Perturbations Induced by the HSP90 Inhibitor XL888
Susan K. Lyman(Exelixis (United States)), Robert A. Blake(Exelixis (United States))
Cited by 35
Related Papers
Randomised trial of efficacy and safety of oral ganciclovir in the prevention of cytomegalovirus disease in liver-transplant recipients
|The Lancet|1997|501
Antibody Conjugation of a Chimeric BET Degrader Enables <i>in vivo</i> Activity
|ChemMedChem|2019|193
Antibody-Mediated Delivery of Chimeric BRD4 Degraders. Part 2: Improvement of In Vitro Antiproliferation Activity and In Vivo Antitumor Efficacy
|Journal of Medicinal Chemistry|2021|168